| |||||||||
This excerpt taken from the TPTX DEF 14A filed Jun 19, 2009. Basis of Consolidation The accompanying consolidated financial statements include the accounts of TorreyPines Therapeutics, Inc., TPTX, Inc. and our wholly owned subsidiaries located in Belgium and the Netherlands. The Netherlands subsidiary was acquired in the Merger and the operations of the Netherlands subsidiary were discontinued in November 2006. The operations of the Belgium subsidiary were discontinued in December 2008. All significant intercompany accounts and transactions are eliminated in consolidation. These excerpts taken from the TPTX 10-K filed Mar 27, 2009. Basis of Consolidation The accompanying consolidated financial statements include the accounts of TorreyPines Therapeutics, Inc., TPTX, Inc. and our wholly owned subsidiaries located in Belgium and the Netherlands. The Netherlands subsidiary was acquired in the Merger and the operations of the Netherlands subsidiary were discontinued in November 2006. The operations of the Belgium subsidiary were discontinued in December 2008. All significant intercompany accounts and transactions are eliminated in consolidation. Basis of Consolidation
These excerpts taken from the TPTX 10-K filed Mar 31, 2008. Basis of Consolidation The accompanying consolidated financial statements include the accounts of TorreyPines Therapeutics, Inc., TPTX, Inc. and our wholly owned subsidiaries located in Belgium and the Netherlands. The Netherlands subsidiary was acquired in the Merger and the operations of the Netherlands subsidiary were discontinued in November 2006. All significant intercompany accounts and transactions are eliminated in consolidation. Basis of Consolidation The accompanying consolidated financial statements include the accounts of TorreyPines Therapeutics, Inc., TPTX, Inc. and our wholly owned This excerpt taken from the TPTX 10-K filed Mar 29, 2007. The accompanying consolidated financial statements include the accounts of TorreyPines Therapeutics, Inc. and our wholly owned subsidiaries located in Belgium and the Netherlands. All significant intercompany accounts and transactions are eliminated in consolidation. The Netherlands subsidiary was acquired in the Merger and the operations of the Netherlands subsidiary were discontinued in November 2006. The subsidiary had no assets or liabilities, therefore there was no extraordinary gain or loss resulting from the disposal. This excerpt taken from the TPTX 8-K filed Dec 13, 2006. Basis of Consolidation The accompanying consolidated financial statements include the accounts of TPTX, Inc. and its wholly owned subsidiary located in Belgium. All significant intercompany accounts and transactions are eliminated in consolidation. The subsidiary is in the start-up phase and has not commenced formal operations. | EXCERPTS ON THIS PAGE:
RELATED TOPICS for TPTX: |
